108 related articles for article (PubMed ID: 7645637)
1. Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.
Hauth JC; Goldenberg RL; Parker CR; Copper RL; Cutter GR
Am J Obstet Gynecol; 1995 Aug; 173(2):578-84. PubMed ID: 7645637
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
Hauth J; Sibai B; Caritis S; VanDorsten P; Lindheimer M; Klebanoff M; MacPherson C; Landon M; Paul R; Miodovnik M; Meis P; Dombrowski M; Thurnau G; Walsh S; McNellis D; Roberts JM
Am J Obstet Gynecol; 1998 Nov; 179(5):1193-9. PubMed ID: 9822499
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
[TBL] [Abstract][Full Text] [Related]
4. Low-dose aspirin therapy to prevent preeclampsia.
Hauth JC; Goldenberg RL; Parker CR; Philips JB; Copper RL; DuBard MB; Cutter GR
Am J Obstet Gynecol; 1993 Apr; 168(4):1083-91; discussion 1091-3. PubMed ID: 8475955
[TBL] [Abstract][Full Text] [Related]
5. Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin.
Finneran MM; Gonzalez-Brown VM; Smith DD; Landon MB; Rood KM
Am J Obstet Gynecol; 2019 Apr; 220(4):385.e1-385.e6. PubMed ID: 30786253
[TBL] [Abstract][Full Text] [Related]
6. The effect of low-dose aspirin on fetal urine output and amniotic fluid volume.
Maher JE; Owen J; Hauth J; Goldenberg R; Parker CR; Copper RL
Am J Obstet Gynecol; 1993 Oct; 169(4):885-8. PubMed ID: 8238144
[TBL] [Abstract][Full Text] [Related]
7. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin.
Louden KA; Broughton Pipkin F; Heptinstall S; Fox SC; Tuohy P; O'Callaghan C; Mitchell JR; Symonds EM
Br J Obstet Gynaecol; 1994 Mar; 101(3):203-8. PubMed ID: 8193093
[TBL] [Abstract][Full Text] [Related]
8. Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.
Regan CL; McAdam BF; McParland P; Boylan PC; FitzGerald GA; Fitzgerald DJ
Br J Obstet Gynaecol; 1998 Jul; 105(7):732-8. PubMed ID: 9692413
[TBL] [Abstract][Full Text] [Related]
9. The effect of low-dose aspirin on umbilical artery Doppler measurements.
Owen J; Maher JE; Hauth JC; Goldenberg RL; Parker CR
Am J Obstet Gynecol; 1993 Oct; 169(4):907-11. PubMed ID: 8238148
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
[TBL] [Abstract][Full Text] [Related]
11. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.
Ayala DE; Ucieda R; Hermida RC
Chronobiol Int; 2013 Mar; 30(1-2):260-79. PubMed ID: 23004922
[TBL] [Abstract][Full Text] [Related]
12. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group.
Br J Obstet Gynaecol; 1996 Jan; 103(1):39-47. PubMed ID: 8608096
[TBL] [Abstract][Full Text] [Related]
13. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Caritis S; Sibai B; Hauth J; Lindheimer MD; Klebanoff M; Thom E; VanDorsten P; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G
N Engl J Med; 1998 Mar; 338(11):701-5. PubMed ID: 9494145
[TBL] [Abstract][Full Text] [Related]
14. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Sibai BM; Caritis SN; Thom E; Klebanoff M; McNellis D; Rocco L; Paul RH; Romero R; Witter F; Rosen M
N Engl J Med; 1993 Oct; 329(17):1213-8. PubMed ID: 8413387
[TBL] [Abstract][Full Text] [Related]
15. Are pill counts valid measures of compliance in clinical obstetric trials?
DuBard MB; Goldenberg RL; Copper RL; Hauth JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1181-2. PubMed ID: 8238182
[TBL] [Abstract][Full Text] [Related]
16. Low-dose aspirin in pregnancy.
Sibai BM; Mirro R; Chesney CM; Leffler C
Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
[TBL] [Abstract][Full Text] [Related]
18. An aspirin a day to prevent prematurity.
Sibai BM
Clin Perinatol; 1992 Jun; 19(2):305-17. PubMed ID: 1617877
[TBL] [Abstract][Full Text] [Related]
19. Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers.
Cole AT; Filipowicz B; Hyman-Taylor P; Hawkey CJ
Aliment Pharmacol Ther; 1994 Oct; 8(5):521-6. PubMed ID: 7865644
[TBL] [Abstract][Full Text] [Related]
20. Aspirin resistance may be associated with adverse pregnancy outcomes.
Wójtowicz A; Undas A; Huras H; Musiał J; Rytlewski K; Reroń A; Wilczak M; Jach R
Neuro Endocrinol Lett; 2011; 32(3):334-9. PubMed ID: 21670728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
